Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan
Author:
Funder
Taipei Veterans General Hospital
Centers for Disease Control, R.O.C. (Taiwan)
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
http://link.springer.com/article/10.1007/s10096-017-3156-8/fulltext.html
Reference42 articles.
1. Metan G, Akova M (2016) Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done? Curr Opin Infect Dis 29:555–560
2. Petrosillo N, Giannella M, Lewis R, Viale P (2013) Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti-Infect Ther 11:159–177
3. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K (1997) Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 41:563–569
4. MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM (1997) Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 350:783
5. Walsh TR (2010) Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 36(Suppl 3):S8–14
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mortality-related risk factors of carbapenem-resistant Enterobacteriaceae infection with focus on Antimicrobial regimens optimization: a real-world study in China;2024-01-24
2. Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study;Infection and Drug Resistance;2024-01
3. Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model;Antibiotics;2023-12-12
4. Monotherapy is associated with a lower risk of mortality in patients infected with carbapenem-resistant Enterobacteriaceae without sepsis;2023-03-23
5. Characterisation of Non-Carbapenemase-Producing Carbapenem-Resistant Klebsiella pneumoniae Based on Their Clinical and Molecular Profile in Malaysia;Antibiotics;2022-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3